HomeCompareIACYF vs JNJ

IACYF vs JNJ: Dividend Comparison 2026

IACYF yields 2.97% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IACYF wins by $123.06M in total portfolio value
10 years
IACYF
IACYF
● Live price
2.97%
Share price
$9.88
Annual div
$0.29
5Y div CAGR
93.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$123.09M
Annual income
$112,917,082.48
Full IACYF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — IACYF vs JNJ

📍 IACYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIACYFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IACYF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IACYF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IACYF
Annual income on $10K today (after 15% tax)
$252.12/yr
After 10yr DRIP, annual income (after tax)
$95,979,520.11/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, IACYF beats the other by $95,975,534.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IACYF + JNJ for your $10,000?

IACYF: 50%JNJ: 50%
100% JNJ50/50100% IACYF
Portfolio after 10yr
$61.56M
Annual income
$56,460,885.94/yr
Blended yield
91.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

IACYF
No analyst data
Altman Z
8.0
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IACYF buys
0
JNJ buys
0
No recent congressional trades found for IACYF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIACYFJNJ
Forward yield2.97%2.13%
Annual dividend / share$0.29$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR93.5%28%
Portfolio after 10y$123.09M$30.3K
Annual income after 10y$112,917,082.48$4,689.40
Total dividends collected$122.30M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IACYF vs JNJ ($10,000, DRIP)

YearIACYF PortfolioIACYF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,274$573.94$10,592$272.30+$682.00IACYF
2$13,233$1,170.15$11,289$357.73+$1.9KIACYF
3$16,643$2,483.89$12,123$472.89+$4.5KIACYF
4$23,458$5,649.45$13,141$629.86+$10.3KIACYF
5$39,500$14,399.57$14,408$846.81+$25.1KIACYF
6$86,113$43,847.92$16,021$1,151.60+$70.1KIACYF
7$265,010$172,869.98$18,122$1,588.22+$246.9KIACYF
8$1,245,646$962,084.80$20,930$2,228.20+$1.22MIACYF
9$9,510,750$8,177,909.14$24,792$3,191.91+$9.49MIACYF
10$123,093,585$112,917,082.48$30,274$4,689.40+$123.06MIACYF

IACYF vs JNJ: Complete Analysis 2026

IACYFStock

Inter Action Corporation engages in the manufacture and sale of illuminators and lens modules used for quality inspections for semiconductor manufacturing in Japan. The company operates through three segments: Internet of Things Related Works; Environmental Energy Related Works; and Promotion Business of Industry 4.0. It offers e inspection illuminators and pupil lens modules for use in quality inspections in the image sensor production process. The company also manufactures drying deodorizers for web offset printing presses; and exhaust gas treatment systems for factories. In addition, it provides precision vibration isolation systems to display manufacturers; and gear testing systems to gear manufacturers. The company was founded in 1992 and is headquartered in Yokohama, Japan.

Full IACYF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this IACYF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IACYF vs SCHDIACYF vs JEPIIACYF vs OIACYF vs KOIACYF vs MAINIACYF vs ABBVIACYF vs MRKIACYF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.